Generally, patients become symptomatic within the first three postoperative days following sevoflurane use with rapid elevations in ALT and AST consistent with a hepatocellular pattern of damage, new-onset mental status changes, and clinically apparent coagulopathy [5–7]. This evidence concerns the gene GPT and blood coagulation disease.